The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery.The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery. Artificial Intelligence, Venture Capital, Drugs (Pharmaceuticals), Start-ups, Eli Lilly and Company, Index Ventures LLP, Novartis AG, Pfizer Inc, Sequoia Capital, Chai Discovery Read More
Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million
